Sperm Donor CMV Status: What Intended Parents Need to Know Before IVF or Surrogacy

Cytomegalovirus (CMV) screening is a routine infectious disease test that helps fertility clinics safely match sperm donors with egg providers and gestational surrogates.

A positive CMV result simply indicates past viral exposure rather than a measure of sperm quality, genetic health or fertility potential. Most CMV-positive donors remain fully eligible to donate, and clinics regularly clear their samples for embryo creation.

If you are preparing for IVF or evaluating donor options, you can contact a surrogacy specialist to learn how donor selection integrates into your broader treatment plan.

What Does CMV Positive or CMV Negative Mean for a Sperm Donor?

Cytomegalovirus is a common, typically harmless virus in the herpesvirus family that infects most adults at some point in their lives. Once a person contracts CMV, their immune system develops antibodies that remain in the bloodstream permanently, even though the virus itself goes dormant.

A “CMV-positive” designation on a donor profile means the donor carries antibodies from a previous exposure. A “CMV-negative” label means the donor has never been infected with the virus.

Sperm banks display CMV status on profiles so fertility clinics can evaluate immunological compatibility between the donor, the egg provider and the person carrying the pregnancy.

CMV IgG vs. IgM: Which Test Actually Matters?

Fertility clinics rely on two distinct blood antibody tests to evaluate a donor’s CMV status: IgG and IgM. Understanding the difference prevents intended parents from unnecessarily ruling out safe, high-quality sperm donors:

• CMV IgG (Immunoglobulin G): Indicates a historical exposure or past infection. A positive IgG result means the donor contracted CMV months or years ago, developed immunity and presents no active risk of transmitting an infection.
• CMV IgM (Immunoglobulin M): Indicates a current, recent or active infection. A positive IgM result signals that the virus may be active, which temporarily pauses tissue donation until the infection resolves.

Intended parents often worry when they see “CMV Positive” on a donor profile, assuming it poses an active health threat. In reality, sperm banks only release donor vials if the donor tests negative for CMV IgM, confirming that no active infection is present.

Why Active CMV Infection Is Different From Previous Exposure

An active CMV infection (IgM positive) presents a temporary risk of viral shedding in bodily fluids, including semen. Sperm banks strictly quarantine and reject donor samples collected during an active CMV flare to protect intended parents and surrogates from acute transmission.

In contrast, a historical exposure (IgG positive, IgM negative) means the viral threat has passed. The donor’s body has safely contained the virus, leaving behind protective antibodies that pose no danger during laboratory fertilization.

Can You Use a CMV-Positive Sperm Donor?

Yes, intended parents can safely use a CMV-positive donor in most clinical situations. Because a vast majority of the adult population carries CMV IgG antibodies, eliminating CMV-positive donors would drastically restrict your donor pool without providing a clear medical benefit.

Fertility clinics evaluate CMV compatibility by reviewing the medical records of the person carrying the pregnancy:

• If the recipient is CMV-positive: The recipient already possesses CMV antibodies. They can safely use either a CMV-positive or CMV-negative sperm donor.
• If the recipient is CMV-negative: The recipient lacks CMV antibodies. Clinics traditionally prefer a CMV-negative sperm donor to avoid any theoretical risk of viral reactivation, though many clinics permit CMV-positive (IgG only) donors following a medical waiver.

Your treating reproductive endocrinologist makes the final clinical determination regarding donor compatibility. Always consult your fertility physician before purchasing non-refundable donor vials.

Does CMV Status Affect IVF Success?

CMV status has zero impact on sperm count, motility, morphology, fertilization rates or blastocyst quality. Infectious disease screening operates entirely separately from a donor’s fertility potential.

When evaluating potential for IVF success, intended parents should focus on criteria that directly influence embryo development:

• Genetic carrier screening compatibility: Ensures the donor does not share recessive genetic mutations with the egg provider.
• Total motile sperm count: Guarantees sufficient viable sperm per vial for conventional IVF or ICSI.
• Proven fertility history: Indicates whether the donor’s samples have produced successful pregnancies in previous cycles.
• Multi-generational medical history: Screens for hereditary health conditions across three generations.

Focusing too heavily on a donor’s historical CMV status can distract from essential genetic and clinical factors that directly dictate embryo health. You can read more about balancing these considerations in our guide on choosing a sperm donor.

Does CMV Status Matter More During Pregnancy?

CMV status matters primarily during active pregnancy because a primary CMV infection contracted during gestation can pass to the fetus, causing congenital CMV. Congenital CMV can lead to hearing loss, vision impairment, developmental delays or microcephaly in newborn infants.

However, congenital CMV risks stem almost exclusively from a pregnant person contracting an active, primary infection during pregnancy—not from washed, cryopreserved donor sperm used in IVF. Fertility clinics review recipient health records carefully to verify antibody status before approving embryo transfer procedures.

Does a Gestational Surrogate’s CMV Status Matter?

When working with a gestational carrier, your fertility clinic evaluates the surrogate’s CMV antibody status during her initial medical screening. If your created embryos were formed using a CMV-positive sperm donor, the clinic will cross-reference the surrogate’s medical records to ensure clinical safety.

While surrogacy agencies coordinate candidate profiles, the fertility clinic’s medical team holds exclusive authority over final medical clearance. If a CMV-negative surrogate is matched with embryos created from a CMV-positive donor, the physician will determine whether to proceed based on the clinic’s specific infectious disease protocols.

When IVF May Lead to a Conversation About Surrogacy

Selecting donor sperm and creating embryos are early milestones that often occur before intended parents select their final path to parenthood. If you create healthy, viable embryos through IVF but experience repeated implantation failure, uterine factor infertility or severe maternal health risks, gestational surrogacy becomes a practical next step.

Surrogacy addresses challenges related to carrying a pregnancy rather than embryo creation. Transferring your existing, genetic-screening-cleared embryos to a pre-screened gestational carrier preserves your biological investment while providing a safe uterine environment for your child to develop.

If you have experienced repeated setbacks during fertility treatments, reviewing surrogacy after failed IVF can help you decide whether transitioning to a carrier fits your goals.

How Gestational Surrogacy Works After Embryos Are Created

If you have already selected your sperm donor and created frozen embryos, transitioning to gestational surrogacy follows a structured, well-coordinated timeline:

1. Surrogate matching: You match with a pre-screened gestational surrogate through a mutual selection process based on shared expectations.
2. Medical screening: Your fertility clinic evaluates the surrogate’s health history, uterine lining and CMV status before issuing formal clearance.
3. Legal agreements: Independent attorneys draft a gestational carrier agreement establishing parental rights, custody and financial parameters.
4. Embryo transfer: The fertility clinic thaws a single frozen embryo and transfers it to the surrogate’s prepared uterus.
5. Birth and parentage: The surrogate delivers at a local hospital, and you take immediate legal and physical custody of your newborn.

Throughout this process, the gestational surrogate has no genetic connection to the baby. For a complete overview of the journey, explore the 5 steps to the surrogacy process.

Get Guidance on Building Your Family Through Surrogacy

Coordinating donor selection, IVF clinic requirements and surrogacy logistics requires experienced oversight. Working with a dedicated professional ensures your embryos are created, stored and transferred under optimal medical and legal conditions.

American Surrogacy assists intended parents by streamlining the surrogate matching process and managing administrative complexities. Average matching wait times run 1–6 months through active national surrogate recruitment.

Intended parents can choose between full-service options based on their financial preferences:

• Foundation Program: Averages $187,500+ with a traditional fee structure for parents comfortable assuming rematch risks if a disruption occurs.
• Limited Risk Program: Averages $202,500+ and incorporates built-in financial protections covering rematching agency fees for qualifying journey disruptions.
• Independent Program: Provides targeted screening, legal coordination and escrow oversight for intended parents who bring their own surrogate candidate.

If you have questions about integrating donor selection into your surrogacy plans, contact an experienced specialist today to build a personalized family-building strategy.